Karol Makowski

Dr. Karol Makowski


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2013 in Journal of Human Hypertension
Verified
Journal Article
Closed access
KMKarol Makowski
Karol Makowski
GGG Gielerak
G Gielerak
EKE Kramarz
E Kramarz
SWSlawomir T. Wierzchon
Slawomir T. Wierzchon
GKGrzegorz Wiktor Kamiński
Grzegorz Wiktor Kamiński
ASA Skrobowski
A Skrobowski

22 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TBThomas Baumgartner
Thomas Baumgartner
MKMiriam Kaelin-Friedrich
Miriam Kaelin-Friedrich
KMKarol Makowski
Karol Makowski
FNFabian Noti
Fabian Noti
BSBeat Schaer
Beat Schaer
TRTobias Reichlin
Tobias Reichlin
Background: A pace and ablate strategy may be performed in refractory atrial fibrillation with rapid ventricular response. Objective: We aimed to assess sex-related differences in patient selection and clinical outcomes after pace and ablate. Methods: In a retrospective multicentre study, patients undergoing AV junction ablation were studied. Sex-related differences in baseline characteristics, all-cause mortality, heart failure (HF) hospitalizations, and device-related complications were assessed. Results: Overall, 513 patients underwent AV junction ablation (median age 75 years, 50% men). At baseline, men were younger (72 vs. 78 years, p < 0.001), more frequently had non-paroxysmal AF (82% vs. 72%, p = 0.006), had a lower LVEF (35% vs. 55%, p < 0.001) and more frequently had cardiac resynchronization therapy (75% vs. 25%, p < 0.001). Interventional complications were rare in both groups (1.2% vs. 1.6%, p = 0.72). Patients were followed for a median of 42 months in survivors (IQR 22–62). After 4 years of follow-up, the combined endpoint of all-cause death or HF hospitalization occurred more often in men (38% vs. 27%, p = 0.008). The same was observed for HF hospitalizations (22% vs. 11%, p = 0.021) and all-cause death (28% vs. 21%, p = 0.017). Sex category remained an independent predictor of death or HF hospitalization after adjustment for age, LVEF and type of stimulation. Lead-related complications, infections, and upgrade to ICD or CRT occurred in 2.1%, 0.2% and 3.5% of patients, respectively. Conclusions: Pace and ablate is safe with a need for subsequent device-related re-interventions in 5.8% over 4 years. We found significant sex-related differences in patient selection, and women had a more favourable clinical course after AV junction ablation.

3 October 2013 in Cardiology Journal
Verified
Journal Article
Open access
KMKarol Makowski
Karol Makowski
EKElżbieta Kramarz
Elżbieta Kramarz
To evaluate the usefulness of the Holter method of sinoatrial conduction time (SACT) calculation in predicting the future occurrence of sinus node disease, and the emergence of indications for permanent pacing in patients with unexplained syncope. The study group included 218 patients (mean age 55 ± 17 years, 116 men) with syncope of unknown etiology in whom spontaneous atrial premature depolarizations (APDs) occurred during Holter monitoring and SACT could be calculated. A SACT value during daily activity > 150 ms was assumed as abnormal. The prospective observation time was 48 ± 11 months. During follow-up sinus node disease was diagnosed in 22 persons, including 18 patients with baseline SACT > 150 ms and 4 with SACT < 150 ms. Indications for pacemaker implantation were found in 16 patients, including 13 patients with baseline SACT > 150 ms and 3 with SACT < 150 ms. In subjects with and without sinus node disease diagnosed during the observation period, baseline SACTvalues were 175 ± 52 ms and 87 ± 34 ms, respectively (p < 0.01), and in patients qualified and not qualified for permanent pacing, the respective values were 178 ± 59 ms and 81 ± 38 ms(p < 0.01). Multivariate Cox analysis showed a significant relationship between baseline SACT > 150 ms and a future diagnosis of sinus node disease and pacemaker implantation. The results suggest that the Holter method of SACT calculation is useful in predicting sinus node disease and indications for permanent pacing in patients with unexplained syncope.

1 November 2002
Verified
Journal Article
Closed access
GGGrzegorz Gielerak
Grzegorz Gielerak
KMKarol Makowski
Karol Makowski
EKElzbieta Kramarz
Elzbieta Kramarz
MCMarian Cholewa
Marian Cholewa
EDEwa Dłuzniewska
Ewa Dłuzniewska
ABAgnieszka Bogaj
Agnieszka Bogaj

1 December 2002
Verified
Journal Article
Closed access
KMKarol Makowski
Karol Makowski
GGGrzegorz Gielerak
Grzegorz Gielerak
MCMarian Cholewa
Marian Cholewa
EKElzbieta Kramarz
Elzbieta Kramarz
DMDariusz Michałkiewicz
Dariusz Michałkiewicz
ASAndrzej Skrobowski
Andrzej Skrobowski

1 May 2004
Verified
Journal Article
Closed access
GGGrzegorz Gielerak
Grzegorz Gielerak
KMKarol Makowski
Karol Makowski
EDEwa Dłuzniewska
Ewa Dłuzniewska
ARAnna Roszczyk
Anna Roszczyk
MCMarian Cholewa
Marian Cholewa